Literature DB >> 36004203

The power of the liposome.

Brian N Arnold1, Mara B Antonoff1.   

Abstract

Entities:  

Year:  2021        PMID： 36004203      PMCID： PMC9390415          DOI： 10.1016/j.xjon.2021.05.017

Source DB:  PubMed          Journal:  JTCVS Open        ISSN： 2666-2736


× No keyword cloud information.
  5 in total

1.  Implementing a Thoracic Enhanced Recovery Program: Lessons Learned in the First Year.

Authors:  Linda W Martin; Bethany M Sarosiek; Meredith A Harrison; Traci Hedrick; James M Isbell; Alexander S Krupnick; Christine L Lau; J Hunter Mehaffey; Robert H Thiele; Dustin M Walters; Randal S Blank
Journal:  Ann Thorac Surg       Date:  2018-03-03       Impact factor: 4.330

2.  Randomized trial of bupivacaine with epinephrine versus bupivacaine liposome suspension in patients undergoing minimally invasive lung resection.

Authors:  Benny Weksler; Jennifer L Sullivan; Lana Y Schumacher
Journal:  J Thorac Cardiovasc Surg       Date:  2020-04-11       Impact factor: 5.209

3.  Significant reduction of postoperative pain and opioid analgesics requirement with an Enhanced Recovery After Thoracic Surgery protocol.

Authors:  Syed S Razi; Joy A Stephens-McDonnough; Safi Haq; Michael Fabbro; Aliercy Nunez Sanchez; Richard H Epstein; Nestor R Villamizar; Dao M Nguyen
Journal:  J Thorac Cardiovasc Surg       Date:  2020-04-03       Impact factor: 5.209

4.  Posterior Intercostal Nerve Block With Liposomal Bupivacaine: An Alternative to Thoracic Epidural Analgesia.

Authors:  David C Rice; Juan P Cata; Gabriel E Mena; Andrea Rodriguez-Restrepo; Arlene M Correa; Reza J Mehran
Journal:  Ann Thorac Surg       Date:  2015-04-23       Impact factor: 4.330

5.  Liposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary Complications.

Authors:  Erin M Corsini; Kyle G Mitchell; Nicolas Zhou; Mara B Antonoff; Reza J Mehran; Gabriel E Mena; Ravi Rajaram; Jack A Roth; Boris Sepesi; Stephen G Swisher; Ara A Vaporciyan; Garrett L Walsh; David C Rice; Wayne L Hofstetter
Journal:  Ann Thorac Surg       Date:  2020-10-28       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.